Close Proximity to Mining Is Associated with Increased Prevalence of the Drug Resistance-Associated Mutation dhps540E in Eastern Democratic Republic of the Congo
- PMID: 38861981
- PMCID: PMC11310628
- DOI: 10.4269/ajtmh.23-0355
Close Proximity to Mining Is Associated with Increased Prevalence of the Drug Resistance-Associated Mutation dhps540E in Eastern Democratic Republic of the Congo
Abstract
Increasing sulfadoxine-pyrimethamine (SP) resistance in the Democratic Republic of the Congo (DRC) has threatened its use for prevention of malaria in one of the most malarious countries in the world. Using geographic information on mining operations in the DRC and genetic data on SP drug resistance markers from the 2013-2014 Demographic and Health Surveys, we evaluated associations between close residence to mining and the presence of mutations conferring resistance to sulfadoxine. Close residential proximity to mining was associated with increased prevalence odds ratio (POR) of the dhps540E mutation (POR: 2.11, 95% uncertainty interval: 1.15-3.96) with adjustments for confounding variables and space. Our findings indicate that exposure to mining is associated with increased presence of an antimalarial drug resistance haplotype that threatens effective use of SP for vulnerable populations. Areas actively engaged in mining could be considered for interventions to reduce the spread of emerging drug resistance in the DRC.
Conflict of interest statement
Disclosure: Ethical approval was obtained from the University of North Carolina Institutional Review Board and the Kinshasa School of Public Health.
Authors’ contributions: C. L. Mitchell and J. J. Juliano wrote the original manuscript draft, and M. M. Janko and J. B. Parr contributed substantially to revisions. C. L. Mitchell, M. M. Janko, and J. J. Juliano conceptualized and designed the study. C. L. Mitchell analyzed the data and performed analytic experiments, M. M. Janko and J. J. Juliano provided analytical guidance, and R. Verity, M. M. Kashamuka, J. A. Bailey, A. K. Tshefu, and J. B. Parr facilitated access to the data and contributed analysis materials. All authors read and approved the final manuscript.
Similar articles
-
Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.Malar J. 2018 Jan 9;17(1):17. doi: 10.1186/s12936-017-2160-x. Malar J. 2018. PMID: 29316929 Free PMC article.
-
Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.Am J Trop Med Hyg. 2006 Jul;75(1):152-4. Am J Trop Med Hyg. 2006. PMID: 16837723
-
High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.Infect Genet Evol. 2015 Jul;33:32-6. doi: 10.1016/j.meegid.2015.04.007. Epub 2015 Apr 28. Infect Genet Evol. 2015. PMID: 25934142
-
Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.Acta Trop. 2013 Feb;125(2):163-90. doi: 10.1016/j.actatropica.2012.10.013. Epub 2012 Nov 3. Acta Trop. 2013. PMID: 23131424 Review.
-
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat.Trop Med Health. 2022 Oct 4;50(1):73. doi: 10.1186/s41182-022-00466-9. Trop Med Health. 2022. PMID: 36195896 Free PMC article. Review.
References
-
- van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DE, Roper C, Okell LC, Desai M, Gutman J, Khairallah C, 2019. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: A systematic review and meta-analysis. Lancet Infect Dis 19: 546–556. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources